Evidence map›Paper›PMID 41768111›Full record

ArticleCase reports in nephrology2026

Intersecting Autoimmunities: ANCA and Anti-GBM Overlap in a Patient With Sjögren's Disease.

Mayra Estacio, Joaquín Rodelo-Ceballos, Ligia Calderon, Alejandra Taborda-Murillo

Abstract read
In one paragraph

Article in Case reports in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mayra EstacioFacultad de Ciencias de la Salud, University of Antioquia, Medellín, Colombia, udea.edu.co.ORCID https://orcid.org/0000-0001-6908-2508
Joaquín Rodelo-CeballosFacultad de Ciencias de la Salud, University of Antioquia, Medellín, Colombia, udea.edu.co.ORCID https://orcid.org/0000-0002-9533-6214
Ligia CalderonDepartment of Nephrology, Hospital Universitario San Vicente Fundación, Medellín, Colombia.ORCID https://orcid.org/0000-0002-3441-1305
Alejandra Taborda-MurilloFacultad de Ciencias de la Salud, University of Antioquia, Medellín, Colombia, udea.edu.co.ORCID https://orcid.org/0000-0002-5662-7983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coexistence of antineutrophil cytoplasmic antibodies (ANCAs) and antiglomerular basement membrane (anti-GBM) antibodies defines a rare but clinically significant autoimmune overlap syndrome. This dual positivity can result in rapidly progressive glomerulonephritis, often with poor kidney outcomes. Diagnosis is particularly challenging in patients with underlying systemic autoimmune diseases, such as Sjögren's disease, where overlapping immunopathogenic mechanisms may obscure the clinical picture. Prompt recognition and individualized treatment are critical for optimal management. Case Presentation: We describe a 62-year-old woman with a history of primary Sjögren's disease who presented with acute kidney injury and urinary abnormalities. Serologic tests revealed high titers of myeloperoxidase (MPO)-ANCA and anti-GBM antibodies, as well as ANA and anti-Ro/La positivity. Kidney biopsy demonstrated crescentic glomerulonephritis with linear IgG deposition and significant chronic changes. Immunosuppressive therapy with high-dose corticosteroids was initiated; however, due to advanced fibrosis and glomerulosclerosis, further immunosuppression was not pursued. The patient required dialysis but remained clinically stable during follow-up. Conclusion: This case highlights the diagnostic and therapeutic challenges of dual ANCA and anti-GBM antibody positivity in the context of systemic autoimmunity. In patients with autoimmune disorders such as Sjögren's disease, a high index of suspicion is essential to detect this rare overlap, which often presents with severe kidney impairment. Although kidney prognosis is frequently poor, early identification and appropriate intervention are vital for improving clinical outcomes.

Indexed as

ANCAanti-GBMdual positivityrapidly progressive glomerulonephritisSjögren’s disease

Identifiers

PMID41768111
PMCPMC12949067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.